Welcome to our dedicated page for Delek US Holdings SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Delek US Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Delek US Holdings's regulatory disclosures and financial reporting.
Delek US Holdings is asking stockholders to vote at its virtual 2026 annual meeting on April 20, 2026. Holders of 59,808,421 common shares as of February 27, 2026 can vote online, by phone, mail, or during the webcast.
Stockholders will elect ten directors, cast an advisory vote on executive compensation, approve a new 2026 Long-Term Incentive Plan, and ratify Ernst & Young as independent auditor. The board is majority independent, uses a lead independent director structure, and has five key committees overseeing audit, compensation, governance, ESG, technology, and cyber risk.
The filing details extensive ESG and risk oversight, board refreshment efforts, and a pay-for-performance program tying annual and long-term incentives to financial and strategic goals. In 2025 Delek returned $141.4 million to stockholders through dividends and buybacks and highlights acquisitions and cost initiatives as performance drivers for executive pay decisions.
DK reports notice of securities sales by an affiliate. The filing lists prior sales by Shlomo Zohar: 7,343 common shares sold on 03/04/2026 for $315,749.00 and 22,029 common shares sold on 03/05/2026 for $987,633.50.
The submission also lists multiple scheduled restricted stock vesting entries (2020–2021) and a broker/agent record showing 5,000 common shares associated with Fidelity Brokerage Services LLC.
Delek US Holdings director Ezra Uzi Yemin reported open-market sales of Delek common stock. On March 4, 2026, he sold 18,139 directly owned shares at a weighted average price of $43.17 per share, leaving 240,281 shares held directly.
On the same date, 66,511 shares were sold indirectly through Yemin Investments, LP at the same weighted average price, with 613,145 shares remaining held indirectly. The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on December 3, 2025, using multiple trades between $43.00 and $43.57 per share.
Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan. On March 4–5, 2026, he sold a total of 29,372 shares of Delek US Holdings common stock in several transactions at prices between $43.00 and $45.50 per share. Following these sales, he directly owned 18,989 shares of the company’s common stock. The filing notes that these transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 13, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c).
Delek US Holdings EVP Israel Joseph reported an open-market sale of 38,000 shares of common stock on March 4, 2026 at a weighted average price of $40.65 per share. After this transaction, he directly owned 55,623 shares of Delek US common stock.
The reported price reflects multiple trades with individual sale prices ranging from $40.10 to $40.93 per share, aggregated into a single weighted average figure for disclosure.
Delek US Holdings, Inc. executive vice president of special projects Reuven Spiegel reported an open-market sale of common stock. On March 4, 2026, he sold 20,000 shares at a weighted average price of $42.84 per share, in multiple trades between $42.80 and $42.98. After this sale, he directly owned 48,530 shares of Delek US common stock.
Delek US Holdings, Inc. director William J. Finnerty sold 5,392 shares of common stock in an open‑market transaction at $42.75 per share on March 4, 2026, leaving him with 46,369 directly owned shares after the sale.
Delek US Holdings, Inc. President & CEO Avigal Soreq reported selling a total of 50,000 shares of common stock on March 3, 2026 in three open-market transactions. The weighted average sale prices were $41.71, $40.90, and $39.85 per share, each reflecting multiple trades within stated price ranges. These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. After these sales, Soreq directly holds 251,678 shares of Delek US common stock.
DK affiliate reported a resale notice under Section 144. The filing records a sale of $315,749 for 7,343 common shares by Shlomo Zohar on 03/04/2026. The filing also lists multiple past restricted stock vesting entries with individual share counts and dates as context.